nodes	percent_of_prediction	percent_of_DWPC	metapath
Glucosamine—IFNG—multiple sclerosis	0.162	0.486	CbGaD
Glucosamine—osteoarthritis—Prednisone—multiple sclerosis	0.138	0.5	CpDpCtD
Glucosamine—osteoarthritis—Methylprednisolone—multiple sclerosis	0.138	0.5	CpDpCtD
Glucosamine—MMP9—multiple sclerosis	0.103	0.31	CbGaD
Glucosamine—Azacitidine—Cladribine—multiple sclerosis	0.0768	0.333	CrCrCtD
Glucosamine—Adenosine—Cladribine—multiple sclerosis	0.0768	0.333	CrCrCtD
Glucosamine—Vidarabine—Cladribine—multiple sclerosis	0.0768	0.333	CrCrCtD
Glucosamine—TNF—multiple sclerosis	0.0678	0.204	CbGaD
Glucosamine—CYP2E1—Fingolimod—multiple sclerosis	0.0363	0.474	CbGbCtD
Glucosamine—CYP2E1—Mitoxantrone—multiple sclerosis	0.0171	0.223	CbGbCtD
Glucosamine—CYP2C19—Prednisone—multiple sclerosis	0.00888	0.116	CbGbCtD
Glucosamine—CYP2E1—Dexamethasone—multiple sclerosis	0.00884	0.115	CbGbCtD
Glucosamine—CYP2C19—Dexamethasone—multiple sclerosis	0.00554	0.0724	CbGbCtD
Glucosamine—NFKB2—Betamethasone—Methylprednisolone—multiple sclerosis	0.000177	0.105	CbGdCrCtD
Glucosamine—NFKB2—Dexamethasone—Methylprednisolone—multiple sclerosis	0.000177	0.105	CbGdCrCtD
Glucosamine—NFKB2—Dexamethasone—Betamethasone—multiple sclerosis	0.000174	0.104	CbGdCrCtD
Glucosamine—NFKB2—Betamethasone—Dexamethasone—multiple sclerosis	0.000174	0.104	CbGdCrCtD
Glucosamine—NFKB2—Dexamethasone—Triamcinolone—multiple sclerosis	0.00017	0.101	CbGdCrCtD
Glucosamine—NFKB2—Betamethasone—Triamcinolone—multiple sclerosis	0.00017	0.101	CbGdCrCtD
Glucosamine—NFKB2—Dexamethasone—Prednisone—multiple sclerosis	0.000162	0.0961	CbGdCrCtD
Glucosamine—NFKB2—Betamethasone—Prednisone—multiple sclerosis	0.000162	0.0961	CbGdCrCtD
Glucosamine—NFKB2—Dexamethasone—Prednisolone—multiple sclerosis	0.000158	0.0938	CbGdCrCtD
Glucosamine—NFKB2—Betamethasone—Prednisolone—multiple sclerosis	0.000158	0.0938	CbGdCrCtD
Glucosamine—TNF—Angiopoietin receptor Tie2-mediated signaling—MAPK1—multiple sclerosis	2.31e-05	0.000282	CbGpPWpGaD
Glucosamine—TNF—MAPK Signaling Pathway—BDNF—multiple sclerosis	2.29e-05	0.000281	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—MALT1—multiple sclerosis	2.28e-05	0.000279	CbGpPWpGaD
Glucosamine—NFKB2—Cytokine Signaling in Immune system—IFNG—multiple sclerosis	2.27e-05	0.000279	CbGpPWpGaD
Glucosamine—TNF—IL23-mediated signaling events—IL6—multiple sclerosis	2.25e-05	0.000276	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—ICAM1—multiple sclerosis	2.24e-05	0.000275	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—IRF5—multiple sclerosis	2.24e-05	0.000275	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—CD86—multiple sclerosis	2.21e-05	0.000271	CbGpPWpGaD
Glucosamine—TNF—TGF-beta Receptor Signaling—TGFB1—multiple sclerosis	2.21e-05	0.000271	CbGpPWpGaD
Glucosamine—MMP9—AP-1 transcription factor network—IL6—multiple sclerosis	2.21e-05	0.000271	CbGpPWpGaD
Glucosamine—TNF—Apoptosis-related network due to altered Notch3 in ovarian cancer—MAPK1—multiple sclerosis	2.2e-05	0.00027	CbGpPWpGaD
Glucosamine—TNF—Cardiac Hypertrophic Response—TGFB1—multiple sclerosis	2.18e-05	0.000267	CbGpPWpGaD
Glucosamine—TNF—Selenium Micronutrient Network—IFNG—multiple sclerosis	2.16e-05	0.000264	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—IFIH1—multiple sclerosis	2.14e-05	0.000262	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—IRF8—multiple sclerosis	2.14e-05	0.000262	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—HLA-G—multiple sclerosis	2.14e-05	0.000262	CbGpPWpGaD
Glucosamine—TNF—Cardiac Hypertrophic Response—MAPK1—multiple sclerosis	2.14e-05	0.000262	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—PTPRC—multiple sclerosis	2.12e-05	0.000259	CbGpPWpGaD
Glucosamine—IFNG—Senescence and Autophagy in Cancer—IL6—multiple sclerosis	2.11e-05	0.000258	CbGpPWpGaD
Glucosamine—TNF—Alzheimers Disease—IL1B—multiple sclerosis	2.1e-05	0.000257	CbGpPWpGaD
Glucosamine—TNF—Allograft Rejection—IL1B—multiple sclerosis	2.1e-05	0.000257	CbGpPWpGaD
Glucosamine—IFNG—Immune System—MX1—multiple sclerosis	2.1e-05	0.000257	CbGpPWpGaD
Glucosamine—TNF—Apoptosis—FAS—multiple sclerosis	2.09e-05	0.000256	CbGpPWpGaD
Glucosamine—TNF—Allograft Rejection—IL2—multiple sclerosis	2.09e-05	0.000256	CbGpPWpGaD
Glucosamine—NFKB2—Regulation of toll-like receptor signaling pathway—IL6—multiple sclerosis	2.08e-05	0.000255	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	2.07e-05	0.000253	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—HLA-B—multiple sclerosis	2.06e-05	0.000253	CbGpPWpGaD
Glucosamine—NFKB2—Toll-Like Receptors Cascades—IL6—multiple sclerosis	2.06e-05	0.000252	CbGpPWpGaD
Glucosamine—TNF—Regulation of toll-like receptor signaling pathway—TLR4—multiple sclerosis	2.05e-05	0.000251	CbGpPWpGaD
Glucosamine—CYP2E1—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	2.05e-05	0.000251	CbGpPWpGaD
Glucosamine—TNF—TWEAK Signaling Pathway—IL6—multiple sclerosis	2.04e-05	0.000249	CbGpPWpGaD
Glucosamine—NFKB2—Cytokine Signaling in Immune system—IL1B—multiple sclerosis	2.03e-05	0.000248	CbGpPWpGaD
Glucosamine—IFNG—Immune System—HLA-DRA—multiple sclerosis	2.03e-05	0.000248	CbGpPWpGaD
Glucosamine—NFKB2—Cytokine Signaling in Immune system—IL2—multiple sclerosis	2.02e-05	0.000247	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—CCL2—multiple sclerosis	2.01e-05	0.000246	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—TNFAIP3—multiple sclerosis	2.01e-05	0.000246	CbGpPWpGaD
Glucosamine—IFNG—Cytokine Signaling in Immune system—TYK2—multiple sclerosis	1.97e-05	0.000241	CbGpPWpGaD
Glucosamine—TNF—MAPK Signaling Pathway—FAS—multiple sclerosis	1.96e-05	0.00024	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—LINGO1—multiple sclerosis	1.95e-05	0.000239	CbGpPWpGaD
Glucosamine—TNF—Signaling events mediated by HDAC Class I—STAT3—multiple sclerosis	1.94e-05	0.000237	CbGpPWpGaD
Glucosamine—MMP9—Spinal Cord Injury—MYC—multiple sclerosis	1.94e-05	0.000237	CbGpPWpGaD
Glucosamine—MMP9—Spinal Cord Injury—TGFB1—multiple sclerosis	1.93e-05	0.000237	CbGpPWpGaD
Glucosamine—TNF—Selenium Micronutrient Network—IL1B—multiple sclerosis	1.92e-05	0.000236	CbGpPWpGaD
Glucosamine—MMP9—Extracellular matrix organization—ICAM1—multiple sclerosis	1.92e-05	0.000236	CbGpPWpGaD
Glucosamine—IFNG—Spinal Cord Injury—IL6—multiple sclerosis	1.92e-05	0.000235	CbGpPWpGaD
Glucosamine—IFNG—Immune System—NOD1—multiple sclerosis	1.91e-05	0.000234	CbGpPWpGaD
Glucosamine—NFKB2—SIDS Susceptibility Pathways—IL6—multiple sclerosis	1.9e-05	0.000232	CbGpPWpGaD
Glucosamine—MMP9—Spinal Cord Injury—MAPK1—multiple sclerosis	1.89e-05	0.000232	CbGpPWpGaD
Glucosamine—TNF—Regulation of toll-like receptor signaling pathway—CD80—multiple sclerosis	1.89e-05	0.000232	CbGpPWpGaD
Glucosamine—IFNG—Immune System—MALT1—multiple sclerosis	1.85e-05	0.000226	CbGpPWpGaD
Glucosamine—TNF—Downstream signaling in naïve CD8+ T cells—MAPK1—multiple sclerosis	1.85e-05	0.000226	CbGpPWpGaD
Glucosamine—IFNG—Immune System—IRF5—multiple sclerosis	1.82e-05	0.000223	CbGpPWpGaD
Glucosamine—MMP9—Signaling by SCF-KIT—STAT3—multiple sclerosis	1.81e-05	0.000221	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—CD28—multiple sclerosis	1.81e-05	0.000221	CbGpPWpGaD
Glucosamine—MMP9—Spinal Cord Injury—TNF—multiple sclerosis	1.8e-05	0.000221	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—PTPRC—multiple sclerosis	1.77e-05	0.000217	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—CCR2—multiple sclerosis	1.77e-05	0.000217	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	1.77e-05	0.000217	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—TLR4—multiple sclerosis	1.75e-05	0.000214	CbGpPWpGaD
Glucosamine—TNF—Vitamin B12 Metabolism—IL6—multiple sclerosis	1.74e-05	0.000214	CbGpPWpGaD
Glucosamine—IFNG—Immune System—HLA-G—multiple sclerosis	1.74e-05	0.000213	CbGpPWpGaD
Glucosamine—IFNG—Immune System—IRF8—multiple sclerosis	1.74e-05	0.000213	CbGpPWpGaD
Glucosamine—IFNG—Immune System—IFIH1—multiple sclerosis	1.74e-05	0.000213	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—HLA-DPB1—multiple sclerosis	1.71e-05	0.00021	CbGpPWpGaD
Glucosamine—TNF—Toll-like Receptor Signaling Pathway—IL1B—multiple sclerosis	1.71e-05	0.000209	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—IFNG—multiple sclerosis	1.71e-05	0.000209	CbGpPWpGaD
Glucosamine—NFKB2—Cytokine Signaling in Immune system—STAT3—multiple sclerosis	1.7e-05	0.000208	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—TAGAP—multiple sclerosis	1.69e-05	0.000208	CbGpPWpGaD
Glucosamine—TNF—MicroRNAs in cardiomyocyte hypertrophy—STAT3—multiple sclerosis	1.67e-05	0.000205	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—PRNP—multiple sclerosis	1.67e-05	0.000204	CbGpPWpGaD
Glucosamine—TNF—Transcriptional regulation of white adipocyte differentiation—TGFB1—multiple sclerosis	1.66e-05	0.000204	CbGpPWpGaD
Glucosamine—CYP2E1—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	1.66e-05	0.000204	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—ITGA4—multiple sclerosis	1.65e-05	0.000202	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—CD40—multiple sclerosis	1.65e-05	0.000202	CbGpPWpGaD
Glucosamine—IFNG—Cytokine Signaling in Immune system—IL1B—multiple sclerosis	1.64e-05	0.000201	CbGpPWpGaD
Glucosamine—MMP9—Signaling by SCF-KIT—MAPK1—multiple sclerosis	1.64e-05	0.000201	CbGpPWpGaD
Glucosamine—IFNG—Cytokine Signaling in Immune system—IL2—multiple sclerosis	1.64e-05	0.000201	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—IFNB1—multiple sclerosis	1.64e-05	0.0002	CbGpPWpGaD
Glucosamine—TNF—Allograft Rejection—TGFB1—multiple sclerosis	1.63e-05	0.0002	CbGpPWpGaD
Glucosamine—IFNG—Immune System—TNFAIP3—multiple sclerosis	1.63e-05	0.000199	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—CTLA4—multiple sclerosis	1.62e-05	0.000199	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—CD80—multiple sclerosis	1.61e-05	0.000198	CbGpPWpGaD
Glucosamine—TNF—Alzheimers Disease—MAPK1—multiple sclerosis	1.6e-05	0.000196	CbGpPWpGaD
Glucosamine—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	1.58e-05	0.000194	CbGpPWpGaD
Glucosamine—TNF—Apoptosis—MYC—multiple sclerosis	1.56e-05	0.000191	CbGpPWpGaD
Glucosamine—TNF—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—multiple sclerosis	1.55e-05	0.00019	CbGpPWpGaD
Glucosamine—NFKB2—Cytokine Signaling in Immune system—MAPK1—multiple sclerosis	1.55e-05	0.000189	CbGpPWpGaD
Glucosamine—TNF—MicroRNAs in cardiomyocyte hypertrophy—MAPK1—multiple sclerosis	1.52e-05	0.000186	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—IL1B—multiple sclerosis	1.52e-05	0.000186	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—IL2—multiple sclerosis	1.52e-05	0.000186	CbGpPWpGaD
Glucosamine—CYP2E1—Vitamin A and Carotenoid Metabolism—MAPK1—multiple sclerosis	1.51e-05	0.000185	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—S1PR1—multiple sclerosis	1.48e-05	0.000181	CbGpPWpGaD
Glucosamine—IFNG—Immune System—CD28—multiple sclerosis	1.46e-05	0.000179	CbGpPWpGaD
Glucosamine—MMP9—Spinal Cord Injury—IL6—multiple sclerosis	1.46e-05	0.000178	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—GPC5—multiple sclerosis	1.44e-05	0.000176	CbGpPWpGaD
Glucosamine—IFNG—Immune System—PTPRC—multiple sclerosis	1.44e-05	0.000176	CbGpPWpGaD
Glucosamine—IFNG—Immune System—CCR2—multiple sclerosis	1.44e-05	0.000176	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—MMP9—multiple sclerosis	1.44e-05	0.000176	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—VCAM1—multiple sclerosis	1.43e-05	0.000176	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—HLA-DQA1—multiple sclerosis	1.43e-05	0.000175	CbGpPWpGaD
Glucosamine—TNF—Folate Metabolism—IL6—multiple sclerosis	1.42e-05	0.000174	CbGpPWpGaD
Glucosamine—TNF—TNF alpha Signaling Pathway—MAPK1—multiple sclerosis	1.42e-05	0.000173	CbGpPWpGaD
Glucosamine—IFNG—Immune System—HLA-DPB1—multiple sclerosis	1.39e-05	0.00017	CbGpPWpGaD
Glucosamine—IFNG—Cytokine Signaling in Immune system—STAT3—multiple sclerosis	1.38e-05	0.000169	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—TYK2—multiple sclerosis	1.36e-05	0.000167	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—HLA-DQB1—multiple sclerosis	1.34e-05	0.000164	CbGpPWpGaD
Glucosamine—TNF—Regulation of toll-like receptor signaling pathway—IL1B—multiple sclerosis	1.34e-05	0.000164	CbGpPWpGaD
Glucosamine—IFNG—Immune System—ITGA4—multiple sclerosis	1.34e-05	0.000164	CbGpPWpGaD
Glucosamine—IFNG—Immune System—CD40—multiple sclerosis	1.34e-05	0.000164	CbGpPWpGaD
Glucosamine—MMP9—Axon guidance—TYK2—multiple sclerosis	1.33e-05	0.000163	CbGpPWpGaD
Glucosamine—IFNG—Immune System—IFNB1—multiple sclerosis	1.33e-05	0.000162	CbGpPWpGaD
Glucosamine—IFNG—Immune System—CTLA4—multiple sclerosis	1.32e-05	0.000161	CbGpPWpGaD
Glucosamine—TNF—Toll-like Receptor Signaling Pathway—MAPK1—multiple sclerosis	1.3e-05	0.00016	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—PTPRC—multiple sclerosis	1.3e-05	0.000159	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—CD86—multiple sclerosis	1.29e-05	0.000158	CbGpPWpGaD
Glucosamine—CYP2C19—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	1.28e-05	0.000157	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—CD40LG—multiple sclerosis	1.26e-05	0.000155	CbGpPWpGaD
Glucosamine—MMP9—Signaling by SCF-KIT—IL6—multiple sclerosis	1.26e-05	0.000155	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—RGS1—multiple sclerosis	1.26e-05	0.000154	CbGpPWpGaD
Glucosamine—IFNG—Cytokine Signaling in Immune system—MAPK1—multiple sclerosis	1.25e-05	0.000153	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—CD8A—multiple sclerosis	1.25e-05	0.000153	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—CD4—multiple sclerosis	1.23e-05	0.000151	CbGpPWpGaD
Glucosamine—TNF—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	1.22e-05	0.000149	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—HLA-B—multiple sclerosis	1.2e-05	0.000147	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—GPR65—multiple sclerosis	1.19e-05	0.000146	CbGpPWpGaD
Glucosamine—NFKB2—Cytokine Signaling in Immune system—IL6—multiple sclerosis	1.19e-05	0.000145	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—MYC—multiple sclerosis	1.19e-05	0.000145	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—TGFB1—multiple sclerosis	1.18e-05	0.000145	CbGpPWpGaD
Glucosamine—TNF—Adipogenesis—STAT3—multiple sclerosis	1.18e-05	0.000145	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	1.16e-05	0.000143	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	1.16e-05	0.000143	CbGpPWpGaD
Glucosamine—IFNG—Immune System—VCAM1—multiple sclerosis	1.16e-05	0.000142	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—MAPK1—multiple sclerosis	1.16e-05	0.000142	CbGpPWpGaD
Glucosamine—IFNG—Immune System—HLA-DQA1—multiple sclerosis	1.16e-05	0.000142	CbGpPWpGaD
Glucosamine—TNF—MAPK Signaling Pathway—IL1B—multiple sclerosis	1.15e-05	0.000141	CbGpPWpGaD
Glucosamine—TNF—Selenium Micronutrient Network—IL6—multiple sclerosis	1.13e-05	0.000138	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—IL2RA—multiple sclerosis	1.13e-05	0.000138	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—HLA-A—multiple sclerosis	1.11e-05	0.000136	CbGpPWpGaD
Glucosamine—TNF—Adipogenesis—TGFB1—multiple sclerosis	1.09e-05	0.000134	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CXCL13—multiple sclerosis	1.09e-05	0.000134	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CCR1—multiple sclerosis	1.09e-05	0.000134	CbGpPWpGaD
Glucosamine—TNF—TNF alpha Signaling Pathway—IL6—multiple sclerosis	1.09e-05	0.000133	CbGpPWpGaD
Glucosamine—IFNG—Immune System—HLA-DQB1—multiple sclerosis	1.08e-05	0.000133	CbGpPWpGaD
Glucosamine—IFNG—Immune System—CD86—multiple sclerosis	1.04e-05	0.000128	CbGpPWpGaD
Glucosamine—IFNG—Immune System—CD40LG—multiple sclerosis	1.02e-05	0.000125	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—TLR4—multiple sclerosis	1.02e-05	0.000125	CbGpPWpGaD
Glucosamine—TNF—Regulation of toll-like receptor signaling pathway—MAPK1—multiple sclerosis	1.02e-05	0.000125	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—HLA-DRB1—multiple sclerosis	1.02e-05	0.000125	CbGpPWpGaD
Glucosamine—MMP9—Extracellular matrix organization—TGFB1—multiple sclerosis	1.01e-05	0.000124	CbGpPWpGaD
Glucosamine—IFNG—Immune System—CD8A—multiple sclerosis	1.01e-05	0.000124	CbGpPWpGaD
Glucosamine—TNF—Toll-like Receptor Signaling Pathway—IL6—multiple sclerosis	1e-05	0.000123	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—ICAM1—multiple sclerosis	9.76e-06	0.00012	CbGpPWpGaD
Glucosamine—IFNG—Immune System—HLA-B—multiple sclerosis	9.73e-06	0.000119	CbGpPWpGaD
Glucosamine—IFNG—Cytokine Signaling in Immune system—IL6—multiple sclerosis	9.62e-06	0.000118	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—SRM—multiple sclerosis	9.53e-06	0.000117	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—TYK2—multiple sclerosis	9.47e-06	0.000116	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—CD80—multiple sclerosis	9.4e-06	0.000115	CbGpPWpGaD
Glucosamine—IFNG—Immune System—IL2RA—multiple sclerosis	9.12e-06	0.000112	CbGpPWpGaD
Glucosamine—IFNG—Immune System—HLA-A—multiple sclerosis	9.02e-06	0.00011	CbGpPWpGaD
Glucosamine—TNF—MAPK Signaling Pathway—MYC—multiple sclerosis	8.94e-06	0.000109	CbGpPWpGaD
Glucosamine—TNF—MAPK Signaling Pathway—TGFB1—multiple sclerosis	8.92e-06	0.000109	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—IL6—multiple sclerosis	8.91e-06	0.000109	CbGpPWpGaD
Glucosamine—CYP2E1—Biological oxidations—POMC—multiple sclerosis	8.83e-06	0.000108	CbGpPWpGaD
Glucosamine—TNF—MAPK Signaling Pathway—MAPK1—multiple sclerosis	8.74e-06	0.000107	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—MAPK1—multiple sclerosis	8.67e-06	0.000106	CbGpPWpGaD
Glucosamine—MMP9—Axon guidance—MAPK1—multiple sclerosis	8.45e-06	0.000103	CbGpPWpGaD
Glucosamine—TNF—Adipogenesis—IL6—multiple sclerosis	8.25e-06	0.000101	CbGpPWpGaD
Glucosamine—IFNG—Immune System—TLR4—multiple sclerosis	8.25e-06	0.000101	CbGpPWpGaD
Glucosamine—IFNG—Immune System—HLA-DRB1—multiple sclerosis	8.24e-06	0.000101	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	8.07e-06	9.88e-05	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	8.05e-06	9.86e-05	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—TYK2—multiple sclerosis	7.93e-06	9.71e-05	CbGpPWpGaD
Glucosamine—IFNG—Immune System—ICAM1—multiple sclerosis	7.91e-06	9.69e-05	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	7.89e-06	9.67e-05	CbGpPWpGaD
Glucosamine—TNF—Regulation of toll-like receptor signaling pathway—IL6—multiple sclerosis	7.82e-06	9.58e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CCL3—multiple sclerosis	7.78e-06	9.53e-05	CbGpPWpGaD
Glucosamine—IFNG—Immune System—CD80—multiple sclerosis	7.61e-06	9.32e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—PTGER4—multiple sclerosis	7.49e-06	9.17e-05	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—IFNG—multiple sclerosis	7.43e-06	9.1e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—PGR—multiple sclerosis	7.38e-06	9.03e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—SRM—multiple sclerosis	7.35e-06	9.01e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CXCR3—multiple sclerosis	7.23e-06	8.86e-05	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—CD4—multiple sclerosis	7.17e-06	8.79e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CD28—multiple sclerosis	7.17e-06	8.78e-05	CbGpPWpGaD
Glucosamine—TNF—SIDS Susceptibility Pathways—IL6—multiple sclerosis	7.13e-06	8.73e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CCR2—multiple sclerosis	7.04e-06	8.62e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Biological oxidations—POMC—multiple sclerosis	6.82e-06	8.35e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—CYP27B1—multiple sclerosis	6.72e-06	8.23e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—CYP24A1—multiple sclerosis	6.72e-06	8.23e-05	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—IL6—multiple sclerosis	6.66e-06	8.16e-05	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—STAT3—multiple sclerosis	6.63e-06	8.12e-05	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—IL1B—multiple sclerosis	6.62e-06	8.11e-05	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—IL2—multiple sclerosis	6.6e-06	8.08e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CNR1—multiple sclerosis	6.49e-06	7.95e-05	CbGpPWpGaD
Glucosamine—MMP9—Axon guidance—IL6—multiple sclerosis	6.49e-06	7.95e-05	CbGpPWpGaD
Glucosamine—IFNG—Immune System—TYK2—multiple sclerosis	6.43e-06	7.87e-05	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—TGFB1—multiple sclerosis	6.15e-06	7.53e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—GPC5—multiple sclerosis	6.14e-06	7.52e-05	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—MAPK1—multiple sclerosis	6.03e-06	7.38e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CXCL10—multiple sclerosis	5.85e-06	7.16e-05	CbGpPWpGaD
Glucosamine—IFNG—Immune System—CD4—multiple sclerosis	5.81e-06	7.12e-05	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—TYK2—multiple sclerosis	5.8e-06	7.1e-05	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—TNF—multiple sclerosis	5.74e-06	7.03e-05	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—STAT3—multiple sclerosis	5.55e-06	6.8e-05	CbGpPWpGaD
Glucosamine—IFNG—Immune System—IL1B—multiple sclerosis	5.37e-06	6.57e-05	CbGpPWpGaD
Glucosamine—IFNG—Immune System—IL2—multiple sclerosis	5.35e-06	6.55e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—CYP24A1—multiple sclerosis	5.18e-06	6.35e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—CYP27B1—multiple sclerosis	5.18e-06	6.35e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CD86—multiple sclerosis	5.11e-06	6.26e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—RRM1—multiple sclerosis	5.09e-06	6.23e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	5.06e-06	6.2e-05	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—MAPK1—multiple sclerosis	5.05e-06	6.18e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CCL5—multiple sclerosis	5.03e-06	6.16e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—GPC5—multiple sclerosis	4.74e-06	5.8e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—SPP1—multiple sclerosis	4.66e-06	5.71e-05	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—IL6—multiple sclerosis	4.63e-06	5.67e-05	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—MMP9—multiple sclerosis	4.57e-06	5.59e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CCR5—multiple sclerosis	4.53e-06	5.55e-05	CbGpPWpGaD
Glucosamine—IFNG—Immune System—STAT3—multiple sclerosis	4.5e-06	5.51e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—IL2RA—multiple sclerosis	4.47e-06	5.47e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—APOE—multiple sclerosis	4.13e-06	5.05e-05	CbGpPWpGaD
Glucosamine—IFNG—Immune System—MAPK1—multiple sclerosis	4.09e-06	5.01e-05	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—STAT3—multiple sclerosis	4.06e-06	4.97e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—RRM1—multiple sclerosis	3.93e-06	4.81e-05	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—IL6—multiple sclerosis	3.88e-06	4.75e-05	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—TGFB1—multiple sclerosis	3.76e-06	4.61e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CD80—multiple sclerosis	3.73e-06	4.57e-05	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—MAPK1—multiple sclerosis	3.69e-06	4.52e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—POMC—multiple sclerosis	3.54e-06	4.34e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CCL2—multiple sclerosis	3.47e-06	4.25e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—TYK2—multiple sclerosis	3.15e-06	3.86e-05	CbGpPWpGaD
Glucosamine—IFNG—Immune System—IL6—multiple sclerosis	3.14e-06	3.85e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	3.05e-06	3.73e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—BCHE—multiple sclerosis	2.92e-06	3.58e-05	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—IL6—multiple sclerosis	2.84e-06	3.47e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—IL2—multiple sclerosis	2.62e-06	3.21e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.62e-06	3.21e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.39e-06	2.92e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—BCHE—multiple sclerosis	2.26e-06	2.76e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—STAT3—multiple sclerosis	2.2e-06	2.7e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—MYC—multiple sclerosis	2.05e-06	2.51e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—TGFB1—multiple sclerosis	2.04e-06	2.5e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—MAPK1—multiple sclerosis	2e-06	2.45e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—APOE—multiple sclerosis	1.76e-06	2.15e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—IL6—multiple sclerosis	1.54e-06	1.89e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—POMC—multiple sclerosis	1.51e-06	1.85e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—ALB—multiple sclerosis	1.38e-06	1.69e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—APOE—multiple sclerosis	1.36e-06	1.66e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—POMC—multiple sclerosis	1.17e-06	1.43e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—ALB—multiple sclerosis	1.06e-06	1.3e-05	CbGpPWpGaD
